Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAC vs VAC/VTC in Intermediate Risk Rhabdomyosarcoma
NCT00003958Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Sep 2002
- Primary completion
- Oct 2007
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of topotecan liposome in rhabdomyosarcoma (RMS), sponsored by Children's Oncology Group. Started Sep 2002; status: completed.
02
Drugs
topotecan liposome
03
Conditions
rhabdomyosarcoma (RMS)
Beyond the preview
Go deeper on NCT00003958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003958.